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To quantify the levels of performance (symptom severity) of the computer-vision symptom
scale (CVSS17), confirm its bifactorial structure as detected in an exploratory factor analy-
sis, and validate its factors as subscales.
Methods
By partial credit model (PCM), we estimated CVSS17 measures and the standard error for
every possible raw score, and used these data to determine the number of different perfor-
mance levels in the CVSS17. In addition, through discriminant analysis, we checked that the
scale’s two main factors could classify subjects according to these determined levels of per-
formance. Finally, a separate Rasch analysis was performed for each CVSS17 factor to
assess their measurement properties when used as isolated scales.
Results
We identified 5.8 different levels of performance. Discriminant functions obtained from sam-
ple data indicated that the scale’s main factors correctly classified 98.4% of the cases. The
main factors: Internal symptom factor (ISF) and external symptom factor (ESF) showed
good measurement properties and can be considered as subscales.
Conclusion
CVSS17 scores defined five different levels of performance. In addition, two main factors
(ESF and ISF) were identified and these confirmed by discriminant analysis. These sub-
scales served to assess either the visual or the ocular symptoms attributable to computer
use.
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Introduction
Many of today’s jobs involve prolonged computer use. This increases a worker’s visual
demands and may give rise to an array of computer-related visual and ocular symptoms
(CRVOS) that adversely affect both quality of life[1] and productivity[2]. These symptoms,
also referred to as computer vision syndrome, digital eyestrain, or occupational asthenopia,
may be divided into two main groups[3–5]: internal or visual symptoms like blurred vision
and diplopia and external or ocular symptoms like burning eyes and dry eyes.
Up until 2014, investigating CRVOS had the difficulty that there was no standardized,
objective, reproducible and validated instrument for measuring these symptoms[6] and many
studies used the questionnaire developed by Hayes et al.[1] which test-retest study is known[7]
but whose psychometric properties, like validity or measurement precision, are unknown. In
2014, we presented the first scale for this purpose, the computer-vision symptom scale
(CVSS17)[8] and in 2015 another Spanish group reported the computer vision syndrome
questionnaire (CVS-Q)[9] which factor structure and/or levels of severity are unknown. The
comparison of both questionnaires’ (CVSS17 and CVS-Q) psychometric properties shows that
CVSS17 overcomes the main limitation of the CVS-Q -a suboptimal item-person targeting-
and shows higher measurement precision.
The CVSS17, developed, validated and scored through Rasch analysis, was designed to
provide a patient-reported measure of CRVOS among video display terminal (VDT) work-
ers. The scale contains 17 items with scores ranging from 17 to 53 (a higher score indicates a
greater level of symptoms) and is available in Spanish, English and Italian at http://www.
cvss17.com. Any person can freely access the questionnaire and obtain a score right away.
CVSS17 ensures construct validity and provides measures as a linear interval scale, measur-
ing CRVOS without the main limitations of previously developed instruments [8]. Besides
the construct validity, we studied [8, 10] different types of the CVSS17´s validity by assessing
the association between the CVSS17 scores and other closely related questionnaires, like the
Visual Discomfort Scale (VDS)[11] and the Ocular Surface Disease Index (OSDI)[12]. In
addition, we tested the convergent validity[10] finding an association by which CVSS17
scores are higher as the amplitude of accommodation decrease and when the difference
between the accommodative amplitude and the amplitude, measured by push-down method,
increase.
To be useful, data provided by CVSS17 should be easy to interpret and actionable[13], i.e.
scores guide diagnostic or therapeutic actions/decision making[14]. In respect to this topic,
providing evidence-based thresholds that identify levels of symptoms is useful for the clinical
management of patient [15] as it helps in the score interpretation[16].
Rasch analysis provides the measure and standard error corresponding to every possible
raw score and can be used to determine how many statistically different levels exist across the
score range[17], in questionnaires assessing symptoms these levels of performance represent
the grades of symptoms severity measured. Therefore, this analysis provides proper cutoff val-
ues to transform CVSS17 scores into categorical.
The main factors of the CVSS17 were identified by conventional factor analysis in the initial
validation of the scale[8]. Accordingly, CVSS17 shows a two-factor structure similar to other
models proposed for CRVOS measured either by Hayes questionnaire[3] or by a checklist
composed by some common CRVOS[18]; one factor is related to ocular dryness and the other
is generally caused by refractive, accommodative or vergence anomalies[5]. However, to the
best of our knowledge, the domain structure of these prior models has not been examined to
verify whether their factors represent independent latent traits [19]. This is an important point
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in CROVS analysis because the strategies for diagnosis, management and/or research of these
problems may differ depending on the relative importance of each main factor. In addition,
grouping scale items within domains is essential because they can form subscales that allow for
the assessment of CRVOS at more specific levels[20].
The present study was therefore designed to: 1) determine the number of different perfor-
mance levels of CVSS17 using the method proposed by Wright [17] because is a sample-inde-
pendent method more suitable for clinical samples, typically skewed to healthy or “sick”
people, than the separation ratio provided by Rasch analysis which assumes that the test is tar-
geted on the sample; 2) confirm through discriminant analysis if the main factors described in
our prior work are capable on their own to classify subjects according to these performance
levels; 3) to validate through Rasch analysis CVSS17 factors as independent latent traits able to
measure the specific principal components of CRVOS.
Methods
The study protocol adhered to the tenets of the Declaration of Helsinki and was approved by
the Research Ethics Committee of the Hospital Clı´nico San Carlos (Madrid, Spain). We
obtained electronic informed consent the participants before accessing the questionnaire’s
webpage and before sending the responses.
All p-values provided are two-tailed. Significance was set at p<0.05.
Participants
The following subjects were invited to complete the CVSS17 online over the period May 2012
to November 2013: the members of a trade union (Unión General de Trabajadores), the part-
ners of a health and safety at work organization (Grupo OTP- Prevención de Riesgos Laborales),
the workers of a private company (SIEMENS) and of a public entity (Spanish National Insti-
tute of Statistics, INE).
Subjects were 18 to 65 years old, spoke Spanish, and fulfilled the definition of a VDT worker
established by the Instituto Nacional de Seguridad e Higiene en el Trabajo (INSHT, Spanish
Institute of Health and Safety at Work)[21]. Further inclusion criteria were no ocular disease
or medication that could affect their vision. When fewer than 12 items (two-thirds) were
answered and/or person outfit was over 2.5 the corresponding questionnaires were excluded
from the analysis[8, 20]. Subjects indicating they were over 39 years of age were considered
presbyopes. Furthermore, we took into account neither the refractive status nor any accommo-
dative or binocular problems in the participants’ recruitment.
822 subjects agreed to complete the CVSS17 and, after applying inclusion and exclusion cri-
teria, 26 questionnaires with Outfit> 2.5 were excluded so 796 were finally analyzed (age:
43.9 ± 10 years; 58.04% female; 35.66% non-presbyopes).
Rasch analysis
The Rasch model is an item response theory (IRT) model. The model transforms raw scores to
preserve the distance between the locations of two persons regardless of the particular items
administered. The main IRT concept is that a mathematical model is used to predict the prob-
ability of a person successfully replying to an item according to the person’s ability and item
difficulty[22]. Since the selected items were polychotomous, for Rasch analysis we had to
choose between the partial credit model (PCM, which considers a different rating scale for
each item) and the Andrich rating scale model (RSM, which assumes equal category thresholds
across items). We chose PCM for the reasons provided in our previous paper [8].
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Levels of performance
We used the PCM results provided by WINSTEPS software (ver. 3.92.1, Chicago, IL) to esti-
mate the CVSS17 measures (in logits) and standard errors corresponding to every possible raw
score. We used these data to compute the number of significantly different levels of perfor-
mance according to the methods proposed by Wright[17].
Confirmatory factor analysis
We used the IBM SPSS Statistics package version 22.0 (Statistical Package for Social Sciences)
for factor analysis of data from those subjects who answered every item to confirm the factorial
structure of the items in the scale.
In the exploratory factor analysis of the CVSS17, published in 2014[8], the structure of the
factor model was unknown; rather, data helped us to reveal or to identify the simplified struc-
ture given by the items in CVSS17. In the factor analysis presented in this paper, on the other
hand, the precise structure of the factor model is hypothesized or known and would be con-
firmed with this analysis[23].
Discriminant analysis (DA) is a statistical multivariate technique useful to classify observa-
tion into different groups. The objective of DA is to identify the minimum number of discrim-
inant functions that will provide most of the discriminations among the groups[23]. Given a
set of independent variables, functions discriminates between individuals and allocates each of
them to a group defined by a dependent categorical variable. Therefore, the basic problem in
discriminant analysis is to assign an unknown subject to one of two or more groups on the
basis of a multivariate observation[24]. DA differs from group building techniques in that the
groups must be known in advance. This is the appropriate method if the independent variables
are metric and the dependent variable is non metric[23]. Moreover, it is possible to determine
how successful the classification is.
Thus, we used DA to examine if the two factors of the CVSS17 identified in the exploratory
factor analysis could accurately classify subjects according to the previously defined levels of
performance. To this end, subjects were first grouped according to their level of symptom
severity. Then, the DA was developed for the obtained factors (independent variables) to con-
firm if factors discriminates between different severity levels (dependent variable). A large pro-
portion of subjects correctly assigned to each group was taken to indicate the high
discrimination power of the CVSS17.
Domain structure assessment
For PCM analysis of each of the two CVSS17 domains (main factors), we used WINSTEPS
software to assess the following properties for each domain:
1. Item fit statistics. Both Infit and Outfit mean square fit statistics show the extent to which
the items in the domain comply with Rasch model expectation[25].
2. Dimensionality. The scale is considered unidimensional when there is one latent variable of
interest, and the level of this latent variable is the focus of measurement[22]. Two parame-
ters derived from principal component analysis (PCA) of standardized residuals are used
for this assessment: the amount of raw variance explained by the measure and the eigen-
value of the unexplained variance in the first contrast[25].
3. Person separation index (PSI) and levels of performance. Rasch-based PSI is a reliability
indicator, analogous to Cronbach’s α of traditional test theory in both values and
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construction[26]. This index was obtained through WINSTEPS. Levels of performance
were computed as described above.
4. Targeting. This was established as the difference between the average difficulty of the items
and subjects’ mean level of symptoms [25].
5. Differential Item Functioning (DIF). We examined each main factors’ items to check there
was no difference in the way subgroups (male–female; presbyopes–nonpresbyopes)
answered each item (i.e., no DIF). We used the DIF analysis implemented in WINSTEPS
based on two methods:
i. Mantel-Haenszel method to estimate (log-) odds DIF size and significance from cross-
tabs of observations in the two groups.
ii. Logit-difference (logistic regression) method to estimate the difference between Rasch
item difficulties for the two groups, maintaining everything else constant[27].
The quality of the data obtained in the domain structure assessment stage (except levels of
performance) was assessed according to the criteria of the guidelines proposed by Khadka
et al.[25] for quality assessment of ophthalmologic questionnaires.
Results
CVSS17 scores were mean 31.31, median 31.0, minimum 17.0, maximum 50.0 and their stan-
dard deviation was 7.65. The 95% confidence interval for the population mean was 30.78 to
31.84. PCM summary statistics are provided in S1 Appendix.
The two main factors described by CVSS17 factor analysis was named in accordance to our
previous paper, ESF and ISF[8].
We used the responses of the 600 subjects who answered every item to analyze the differ-
ences in CVSS17, ESF and ISF scores according to gender and age group (non-presbyope
women, non-presbyope men, presbyope women and presbyope men) by Kruskal-Wallis test
followed by Dunn’s multiple comparisons test, because K-S test indicated a normal distribu-
tion neither for CVSS17 scores nor for the main factors’ scores. Kruskal-Wallis test showed
that there was a significant difference between the analyzed groups for CVSS17 (H: 37.01,
p<0.001), ESF (H: 34.08, p<0.001) and ISF (H: 33.51, p<0.001). According to median values
(Table 1) and Dunn’s test results (Table 2), presbyope women showed significant higher values
for CVSS17, ESF and ISF scores. No more significant differences were found.
Levels of performance
Rasch analysis revealed 5.8 different levels of performance and a level reliability of 0.97 (see S2
Appendix for details). CVSS17 performance levels (symptom severity grades) and subject dis-
tributions across these levels are detailed in Table 3.
As only seven subjects were allocated to the top level (level 6), levels 5 and 6 were collapsed
so five levels were finally defined (Fig 1).
Confirmatory factor analysis
For this analysis, we selected questionnaires without missing responses corresponding to 600
subjects (age: 44.4 ± 10; 59.0% female; 33.2% non-presbyopes). CVSS17 scores for these sub-
jects were mean 30.87, median 30.0, minimum 17.0, and maximum 50.0; standard deviation
was 7.82.
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First, as the Bartlett’s sphericity test showed significance, the Kaiser-Meyer-Olkin (KMO)
index was used to verify if our data were suitable for factor analysis. As KMO was 0.94, factor
analysis was performed and the number of principal components determined by selecting fac-
tors with eigenvalues over one. A two-factor structure (rotated component matrix is shown in
Table 4 and a graph showing the factor loading for each one of the principal components in
Fig 2) accounted for 53.87% of the total variability.
Once we had identified the principal components, a univariate descriptive analysis was con-
ducted by calculating the means and standard deviations of the scale’s main factors separately
for each performance group (Table 5).
As shown in Table 5, mean factor values differed across performance levels and their vari-
ability is less than 1 in most cases, indicating that the scale’s main factors could be good at dis-
criminating between groups. This result is confirmed with the DA concluding that the mean
of at least one pair of groups are significantly different (p<0.05 for both factors). Fig 3 shows
the factor loadings for each subject according to subject level of performance.
In addition, the discriminant functions obtained from the main factors were able to cor-
rectly classify 98.3% of the cases examined.
Domain structure assessment
According to previously used nomenclature [4, 18], hereafter items with a Factor 1 loading
(see Table 4) over 0.5 are referred to as an ESF and items with a Factor 2 loading over 0.5 as an
ISF. Rasch analysis results are provided separately for ESF and ISF:
Table 1. Descriptive statistics by age and gender group for CVSS17, External Symptom Factor (ESF) and Internal Symptom Factor (ISF).
Non-presbyope women (NPW) Non-presbyope men (NPM) Presbyope women (PW) Presbyope men (PM) Total
CVSS17
n 135 64 219 182 600
Median 29 26.5 34 28 30
Intercuartile range 24 to 37 21,25 to 33,5 27 to 39 23 to 34,25 25 to 37
External Symptom Factor (ESF)
n 135 64 219 182 600
Median 19 17 21 18 11
Intercuartile range 15 to 34 14 to 22 17 to 26 15 to 23 16 to 24
Internal Symptom Factor (ISF)
n 135 64 219 182 600
Mean 10.93 9.66 11.93 10.6 11.06
Intercuartile range 8 to 13 8 to 11 9 to 14 8 to 13 8 to 13
https://doi.org/10.1371/journal.pone.0202173.t001
Table 2. p-values obtained in Dunn’s post hoc tests for pairwise comparisons results.
CVSS17 ESF ISF
NPM PW PM NPM PW PM NPM PW PM
NPW 0.052 <0.001 1,000 0.110 0.020 1,000 0.052 0.018 1,000
NPM <0.001 0.439 <0.001 0.889 <0.001 0.216
PW <0.001 0.014 <0.001 <0.001 <0.001 <0.001
NPW, NPM, PW and PM are defined in Table 1a heading
 indicates a p-value lower than 0.05
https://doi.org/10.1371/journal.pone.0202173.t002
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Rasch analysis results for ESF. Infit and outfit mean squares were 0.99 and 1.00 respec-
tively for persons, and 1.00 and 1.01 respectively for items. The eigenvalue of the unexplained
variance in the first PCA contrast was 1.71 and raw variance explained by measures was 53%.
PSI was 2.61 and there were 4.7 statistically different levels of performance (Fig 4). The differ-
ence between the average difficulty of the items and subjects was -0.41 logits. DIF for gender
and age group was under 0.5 logits for all items. Table 6 shows our quality assessment of these
results.
Rasch analysis results for ISF
Infit and outfit mean squares were 0.99 and 0.99, respectively, for persons and 0.99 and 0.99
respectively for items. The eigenvalue of the unexplained variance in the first PCA contrast
was 1.78 and raw variance explained by measures was 56.1%. PSI was 1.63 and there were 3.3
statistically different levels of performance (Fig 5). The difference between the average diffi-
culty of the items and subjects was -1.27 logits. DIF for gender and age group was under 0.50
logits for all items. Table 7 shows our quality assessment of these results.
Table 3. CVSS17 levels of performance (symptoms severity).
CVSS17 levels of performance
Level 1 Level 2 Level 3 Level 4 Level 5 Level 6
Score range [17,23) [23,29) [29,36) [36,43) [43,49) [49,53]
n (%) 119 (14.95) 191 (24.00) 245 (30.78) 180 (22.61) 54 (6.78) 7 (0.88)
Score intervals defining each level are described in the first row and the number of subjects (and percentage) classified among each level in the bottom row.
https://doi.org/10.1371/journal.pone.0202173.t003
Fig 1. Plot of the estimated measure for any CVSS17 raw score. Plot of the estimated measure (x-axis) for any raw
CVSS17 score (y-axis). Different symbols represent distinct levels of performance as indicated in the figure inset.
https://doi.org/10.1371/journal.pone.0202173.g001
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Discussion
This study identified five significantly different levels of symptoms among CVSS17 scores and
confirmed the two-factor structure (ESF and ISF) of this scale. By Rasch analysis, it was also
observed that ESF and ISF perform well as separate scales.
Because CVSS17 is a PRO instrument without DIF for gender and/or age group, we could
directly compare the CRVOS among these subgroups, so our results describing a higher level
of CRVOS in women and in presbyopes, despite previously reported[4, 5], are worthy of note
and future studies should consider these differences in their analysis and should go depth in
the research on the reasons that provokes a higher level of CRVOS in presbyope women.
Our analysis detected 5.8 levels of performance or symptoms across the scale’s score range
corresponding to a sample-independent reliability of 0.97. For easy interpretation of CVSS17
scores, we propose five levels of symptom severity whereby categories four and five indicate a
higher level of subject symptoms than scale difficulty. This means that VDT workers assigned
to these levels warrant priority attention. To our knowledge, no similar CRVOS scale shows
such a good grading power, which was comparable to that calculated using the same methods
for the Chinese Impact of Vision Impairment (IVI) questionnaire[28].
By discriminant analysis, we confirmed that the CVSS17’s main factors (ESF and ISF) can
correctly classify subjects’ CRVOS according to their level of symptom severity. A reduced
blink rate associated with computer use, a high cognitive load and low contrast reading condi-
tions lead to ESF symptoms[29–31], while refractive errors, glare, accommodation system
stress[29] and increased convergence[31] may cause ISF symptoms. As mentioned previously
[8], other authors [3, 18] have proposed similar bifactorial models with differences in the
Table 4. Rotated components matrix.
Item descriptor Component
1 2
A32. Did your eyes sting? 0.80 0.21
A21. Did your eyes burn? 0.78 0.15
A9. Did your eyes hurt? 0.74 0.22
A17. After working on the computer for a while did your eyes become heavy? 0.71 0.30
A4. Did your eyes become tired? 0.68 0.34
C16. At the end of my working day, my eyes feel heavy 0.67 0.21
B8. Eye redness 0.63 0.34
A20. Did you have to blink more than usual? 0.59 0.38
C23. While I’m working, I have to close my eyes to relieve eye dryness 0.56 0.36
B7. Watery Eyes 0.53 0.24
A33. After working on the computer for a while did lights bother you? 0.48 0.54
C21. After working at the computer, I have to strain to see well 0.37 0.72
A2. Did the letters on the screen become blurry? 0.33 0.73
A22. Did you have to strain to see well? 0.30 0.67
A30. Did the letters appear double? 0.25 0.73
C24. After some time at the computer, lights bother me 0.24 0.57
A28. Did you feel like you were crossing your eyes? 0.08 0.68
Extraction method was principal-component factors and rotation method was Varimax with kaiser normalization.
The two columns on the right shows each component’s loading and items are displayed on the left column, ordered
by component 1 loading. Items with factor 1’s loading are highlighted in bold and those with factor 2’s loading over
0.5 are in cursive
https://doi.org/10.1371/journal.pone.0202173.t004
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factors assigned to eyestrain and photophobia. To explain these differences, it should be noted
that the items included in a questionnaire determine factor composition. Sheedy et al[3].
selected nine symptoms measured using visual analogue scales (VAS) on a study sample of
twenty students and University staff members, while Portello et al[3]. measured symptoms
among VDT workers with the questionnaire developed by Hayes et al.[1] based on clinical
findings and questionnaires used in the care of computer-using patients. The items included
in CVSS17 were selected through Rasch analysis conducted on a population of VDT workers.
Fig 2. Factor loadings for CVSS17 principal components. Plot of the factor is loading for Factor 1 (external
symptom factor, horizontal axis) against Factor 2 (internal symptom factor, vertical axis) for each of the CVSS17 items.
Item descriptors are shown in Table 4.
https://doi.org/10.1371/journal.pone.0202173.g002
Table 5. Univariate descriptive analysis results.
CVSS17 Level Recoded factor score Mean S.D. n
1 Factor 1 -1.22 0.38 101
Factor 2 -0.67 0.25 101
2 Factor 1 -0.49 0.51 157
Factor 2 -0.48 0.59 157
3 Factor 1 0.21 0.74 167
Factor 2 0.01 0.88 167
4 Factor 1 0.87 0.78 130
Factor 2 0.55 1.05 130
5 Factor 1 1.17 0.65 45
Factor 2 1.55 0.90 45
Total Factor 1 0.00 1.00 600
Factor 2 0.00 1.00 600
Mean and standard deviation are shown for each recoded factor score among every performance group (left
column), Number of valid responses are shown in the right column.
https://doi.org/10.1371/journal.pone.0202173.t005
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Item A33 related to light-induced ocular discomfort showed a similar ESF and ISF factor load-
ing. Thus, it could be that the pathophysiological mechanism that produces ocular discomfort
associated with bright light may have components of both ESF and ISF.
Fig 3. Discriminant analysis scatter plot of the two factors model. Discriminant analysis scatter plot of the two
factors model. Recoded external factor scores (x-axis) are plotted against recoded internal factor scores (y-axis).
Different grey intensities represent distinct subject levels of performance as indicated in the figure inset.
https://doi.org/10.1371/journal.pone.0202173.g003
Fig 4. Plot of the estimated measure for any ESF raw score. Plot of the estimated measure (x-axis) for any ESF raw
score (y-axis). Different symbols represent distinct levels of performance as indicated in the figure inset.
https://doi.org/10.1371/journal.pone.0202173.g004
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ESF items are able to assess dry-eye symptoms related to computer use among VDT work-
ers. In fact, when comparing their measurement properties against those recently described
for the Ocular Comfort Index (OCI), Ocular Surface Disease Index (OSDI) and McMonnies
Questionnaire [19] it emerged that ESF had benefits including better-fit statistics, a lower
eigenvalue of the first PCA contrast, higher person separation and better items-person target-
ing. Accordingly, ESF could be the best option to assess dry eye symptoms in VDT workers.
However, clinical research is still needed to confirm its separate performance by assessing
other properties like repeatability and convergent validity. In addition, to help clinicians
Table 6. Quality evaluation of data obtained in the External Symptom Factor (ESF) domain assessment.
Property Evaluated variable Result Quality grade† (khadka et al.)[25]
Item fit Statistics Number of Items with Infit outside (0.7,1.3) 0 A
Number of Items with Outfit outside (0.7,1.3) 0 A
Dimensionality Raw variance explained by measure 53.0% B
Eigenvalue of the first contrast 1.71 B
Measurement precision Person separation index 2.61 A
Number of statistically different levels (Reliability) 4,7 (0,96) A† †
Targeting Items dificulty - Subjects ability -0.41 A
DIF Number of items with DIF by gender > 0,5 0 A
Number of items with DIF by age group > 0,5 0 A
† A: High; B: Medium; C: Low.
† † Criteria was proposed for empirical reliability derived from Rasch-based person separation index, but in the present study this variable assessment was based on the
sample-independent reliability provided by methods described by Wright[17]
https://doi.org/10.1371/journal.pone.0202173.t006
Fig 5. Plot of the estimated measure for any ISF raw score. Plot of the estimated measure (x-axis) for any ISF raw
score (y-axis). Different symbols represent distinct levels of performance as indicated in the figure inset.
https://doi.org/10.1371/journal.pone.0202173.g005
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managing CRVOS, more research is needed to precise the relationship between clinical find-
ings and the levels of severity and/or the subscales described in the present paper besides the
associations described by us in a previous work between CVSS17 scores and some clinical
measures that are summarized in Table 8.
The results displayed on Table 8 provide some evidence about the CVSS17’s concurrent
validity but we still need to determine the way in which CRVOS vary as some clinical mea-
sures, like uncorrected refractive errors or tear film osmolarity, change. To do so, researchers
need to compare valid and reliable clinical data against a valid and reliable model of CRVOS,
like the one provided by the CVSS17.
According to the PSI, ISF measurement precision was below the acceptable limit given our
participant distribution was skewed towards the less symptomatic part of the scale. However,
by assessing reliability using the Wright method, we confirmed that ISF could distinguish
three strata so at least it can discriminate between high and low performers. We therefore pro-
pose this subscale could be useful to assess internal symptoms among VDT workers.
Table 7. Quality evaluation of data obtained in the Internal Symptom Factor (ISF) domain assessment.
Property Evaluated variable Result Quality grade† (khadka et al.)[25]
Item fit Statistics Number of Items with Infit outside (0.7,1.3) 0 A
Number of Items with Outfit outside (0.7,1.3) 2 B
Dimensionality Raw variance explained by measure 56.1% B
Eigenvalue of the first contrast 1.78 B
Measurement precision Person separation index 1.63 C
Number of statistically different levels (Reliability) 3,3 (0,92) A††
Targeting Items dificulty—Subjects ability -1.27 B
DIF Number of items with DIF by gender > 0,5 0 A
Number of items with DIF by age group > 0,5 0 A
† A: High; B: Medium; C: Low.
†† Criteria was proposed for empirical reliability derived from Rasch-based person separation index, but in the present study this variable assessment was based on the
sample-independent reliability provided by methods described by Wright[17]
https://doi.org/10.1371/journal.pone.0202173.t007
Table 8. Coefficients of correlation between CVSS17 and some clinical measures, previously reported [10].
CVSS17 ESF ISF
VDS 0.66† 0.58†† 0.72††
OSDI 0.65† 0.63†† 0.55††
AA 0.34† n.s. 0.34†
DIFAA 0.37† n.s. -0.42†




VDS = Visual Discomfort Scale. OSDI = Ocular Surface Disease Index. AA = Amplitude of accommodation
measured by push-down method. DIFAA = AA–Mean amplitude of accommodation predicted by Hofstetter
formula. MR = M component of the ocular refraction, measured by retinoscopy. J0R = J0 component of the ocular
refraction measured by retinoscopy. n.s. = non-significant
 = p<0.05
 = p < .01
† = Pearson’s r
†† = Spearman’s rho
https://doi.org/10.1371/journal.pone.0202173.t008
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Notwithstanding, its reliability and persons-item targeting could be improved by adding more
low-difficulty items.
Although more work is needed to compare changes in CVSS17 scores indicating clinically
meaningful variations[32], our data suggest that a change in CVSS17 performance level may
be perceived by a subject. The results showed in the present paper indicate that, besides the
CRVOS level provided by the CVSS17, ESF or ISF are valid measures when defining the opti-
mal assessment strategy and/or treatment for any patient. Table 9 depicts an example of sub-
scales-guided clinical decisions taken from real CVSS17 scores, where Person 1 and Person 2
score is the same, 37, but just looking at their subscales’ scores the clinician would focus on dry
eye when dealing with Person 1 but would consider ocular refraction, accommodation and/or
vergence anomalies when caring for Person 2.
We have to point out that we assessed neither the participants’ refractive status nor their
accommodative or binocular anomalies so an under/overrepresentation of these anomalies in
our sample could lead to an under/overestimation of values like the CVSS17 population mean,
the median values or the number of subjects in each level of performance but it has no effect in
the main findings of the study like the factor structure of the CVSS17 or in the levels of perfor-
mance cut-off scores.
CVSS17 was originally developed and validated in Spanish. Since its development, other
research groups have started its cross-cultural adaptation to English, Italian and Portuguese.
For a better understanding of the CVSS17’s items, we provide the English printable versions of
CVSS17, ESF and ISF along with the original Spanish versions and their scoring charts (S3, S4,
S5, S6, S7, S8, S9, S10 and S11 Appendix). To help clinicians and researchers willing to use the
CVSS17, we include a spreadsheet in English (S12 Appendix) and in Spanish (S13 Appendix)
that automatically provide the CVSS17, ESF and ISF score after entering manually the answers
to the CVSS17 questionnaire. In addition, data used for this research is provided in S1 Dataset.
In conclusion, CVSS17 is a highly reliable PRO (patient reported outcomes) tool to assess
CRVOS in VDT workers, with scores defining five different levels of performance. In addition,
two main factors (ESF and ISF) were identified through factor analysis. These main factors or
subscales were confirmed by discriminant analysis and are consistent with our previous find-
ings. Accordingly, clinicians and/or researchers could separately use the ESF and ISF subscales
to assess the specific components of CRVOS.
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Table 9. Example for subscales’ scores interpretation.
CVSS17 Score CVSS17Level ESF Score ESFLevel ISF Score ISFLevel
Person 1 37 4 31 4 10 1
Person 2 37 4 20 2 18 3
https://doi.org/10.1371/journal.pone.0202173.t009
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